Study selection criteria. حسب Filip Stanicic (17808254)

"…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…"

PICOS criteria for the SLR. حسب Filip Stanicic (17808254)

"…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…"

PRISMA flow chart. حسب Filip Stanicic (17808254)

"…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…"

GRADE judgements. حسب Da Huang (1306407)

"…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …"

Basic characteristics of the included studies. حسب Da Huang (1306407)

"…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …"

The data of meta-analysis. حسب Da Huang (1306407)

"…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …"

Risk of bias. حسب Da Huang (1306407)

"…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …"

Overall risk of bias assessment. حسب Da Huang (1306407)

"…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …"

Funnel plot of VO_2Peak inclusion studies. حسب Da Huang (1306407)

"…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …"

Analysis of subgroups. حسب Da Huang (1306407)

"…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …"

Table 1_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx حسب Stefanie Wagner (743707)

"…In contrast, analysis of relative abundances only showed a decrease of Faecalibacterium and Rikenellaceae RC9 gut group and, thus, a much less detailed antibiotic effect.…"

Table 3_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx حسب Stefanie Wagner (743707)

"…In contrast, analysis of relative abundances only showed a decrease of Faecalibacterium and Rikenellaceae RC9 gut group and, thus, a much less detailed antibiotic effect.…"

Table 4_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx حسب Stefanie Wagner (743707)

"…In contrast, analysis of relative abundances only showed a decrease of Faecalibacterium and Rikenellaceae RC9 gut group and, thus, a much less detailed antibiotic effect.…"

Table 8_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx حسب Stefanie Wagner (743707)

"…In contrast, analysis of relative abundances only showed a decrease of Faecalibacterium and Rikenellaceae RC9 gut group and, thus, a much less detailed antibiotic effect.…"

Table 2_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx حسب Stefanie Wagner (743707)

"…In contrast, analysis of relative abundances only showed a decrease of Faecalibacterium and Rikenellaceae RC9 gut group and, thus, a much less detailed antibiotic effect.…"

Table 6_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx حسب Stefanie Wagner (743707)

"…In contrast, analysis of relative abundances only showed a decrease of Faecalibacterium and Rikenellaceae RC9 gut group and, thus, a much less detailed antibiotic effect.…"

Table 5_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx حسب Stefanie Wagner (743707)

"…In contrast, analysis of relative abundances only showed a decrease of Faecalibacterium and Rikenellaceae RC9 gut group and, thus, a much less detailed antibiotic effect.…"

Table 7_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx حسب Stefanie Wagner (743707)

"…In contrast, analysis of relative abundances only showed a decrease of Faecalibacterium and Rikenellaceae RC9 gut group and, thus, a much less detailed antibiotic effect.…"

Table 9_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx حسب Stefanie Wagner (743707)

"…In contrast, analysis of relative abundances only showed a decrease of Faecalibacterium and Rikenellaceae RC9 gut group and, thus, a much less detailed antibiotic effect.…"

Baseline characteristics of patients. حسب Su Hwan Park (15158181)

"…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …"